Cargando…

Effectiveness of various human papillomavirus vaccination strategies: A community randomized trial in Finland

INTRODUCTION: We conducted a community‐randomized trial (NCTBLINDED) in Finland to assess gender‐neutral and girls‐only vaccination strategies with the AS04‐adjuvanted human papillomavirus (HPV)‐16/18 (AS04‐HPV‐16/18)vaccine. METHODS: Girls and boys (12−15 years) were invited. We randomized 33 commu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lehtinen, Matti, Apter, Dan, Eriksson, Tiina, Harjula, Katja, Hokkanen, Mari, Natunen, Kari, Nieminen, Pekka, Paavonen, Jorma, Palmroth, Johanna, Petäjä, Tiina, Pukkala, Eero, Vänskä, Simopekka, Cheuvart, Brigitte, Soila, Maaria, Bi, Dan, Struyf, Frank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Cancer Prevention
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559511/ https://www.ncbi.nlm.nih.gov/pubmed/34581025 http://dx.doi.org/10.1002/cam4.4299

Ejemplares similares

Effectiveness of the AS04‐adjuvanted HPV‐16/18 vaccine in reducing oropharyngeal HPV infections in young females—Results from a community‐randomized trial
por: Lehtinen, Matti, et al.
Publicado: (2019)

Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point—registry-based follow-up of three cohorts from randomized trials
por: Lehtinen, Matti, et al.
Publicado: (2017)

Vaccination With Moderate Coverage Eradicates Oncogenic Human Papillomaviruses If a Gender-Neutral Strategy Is Applied
por: Vänskä, Simopekka, et al.
Publicado: (2020)

Human papillomavirus vaccine efficacy against invasive, HPV-positive cancers: population-based follow-up of a cluster-randomised trial
por: Lehtinen, Matti, et al.
Publicado: (2021)

Safety of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in adolescents aged 12–15 years: Interim analysis of a large community-randomized controlled trial
por: Lehtinen, Matti, et al.
Publicado: (2016)

Safety of the AS04-adjuvanted human papillomavirus (HPV)-16/18 vaccine in adolescents aged 12–15 years: end-of-study results from a community-randomized study up to 6.5 years
por: Bi, Dan, et al.
Publicado: (2019)

Association of Chlamydia trachomatis infection with cervical atypia in adolescent women with short-term or long-term use of oral contraceptives: a longitudinal study in HPV vaccinated women
por: Adhikari, Indira, et al.
Publicado: (2022)

The Prevalence of HSV, HHV-6, HPV and Mycoplasma genitalium in Chlamydia trachomatis positive and Chlamydia trachomatis Negative Urogenital Samples among Young Women in Finland
por: Korhonen, Suvi, et al.
Publicado: (2019)

Cancer Registry follow‐up for 17 million person‐years of a nationwide maternity cohort
por: Lehtinen, Matti, et al.
Publicado: (2017)

Impact of Vaccination on 14 High-Risk HPV Type Infections: A Mathematical Modelling Approach
por: Vänskä, Simopekka, et al.
Publicado: (2013)

Human papillomavirus seroprevalence in pregnant women following gender-neutral and girls-only vaccination programs in Finland: A cross-sectional cohort analysis following a cluster randomized trial
por: Gray, Penelope, et al.
Publicado: (2021)

Is the risk of cervical atypia associated with the interval between menarche and the start of sexual activity? A population-based cohort study
por: Adhikari, Indira, et al.
Publicado: (2019)

Use of private gynaecologist does not relate to better prevention outcomes – An ecological analysis from Finland
por: Hemminki, Elina, et al.
Publicado: (2006)

Human Papillomavirus Genotype Replacement: Still Too Early to Tell?
por: Man, Irene, et al.
Publicado: (2020)

Prior human papillomavirus‐16/18 AS04‐adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post‐hoc analysis from a randomized controlled trial
por: Garland, Suzanne M., et al.
Publicado: (2016)

A population-based study on the risk of cervical cancer and cervical intraepithelial neoplasia among grand multiparous women in Finland
por: Hinkula, M, et al.
Publicado: (2004)

Incidence of first‐ever transient ischemic attack in Eastern Finland
por: Komulainen, Tiina, et al.
Publicado: (2022)

A discrepancy of Chlamydia trachomatis incidence and prevalence trends in Finland 1983–2003
por: Lyytikäinen, Erika, et al.
Publicado: (2008)

Oral contraceptive use before first birth and risk of breast cancer: a case control study
por: Hemminki, Elina, et al.
Publicado: (2002)

Time trends in socioeconomic differences in incidence rates of cancers of gastro-intestinal tract in Finland
por: Weiderpass, Elisabete, et al.
Publicado: (2006)

Perceived Physical Strain at Work and Incidence of Prostate Cancer – a Case-Control Study in Sweden and Finland
por: Sormunen, Jorma, et al.
Publicado: (2018)

Risk factors, epidemiology and prognosis of cholangiocarcinoma in Finland
por: Barner‐Rasmussen, Nina, et al.
Publicado: (2021)

Malignant Eccrine Porocarcinoma in Finland During 2007 to 2017
por: MERILÄINEN, Anna-Stiina, et al.
Publicado: (2021)

Socioeconomic status and risk of lung cancer by histological subtype in the Nordic countries
por: Pizzato, Margherita, et al.
Publicado: (2022)

Finasteride treatment and male breast cancer: a register‐based cohort study in four Nordic countries
por: Meijer, Mathias, et al.
Publicado: (2017)

Immunopathogenesis of Chlamydial Pelvic Inflammatory Disease: The Role of Heat-Shock Proteins
por: Paavonen, Jorma, et al.
Publicado: (1994)

Sound efficacy of prophylactic HPV vaccination: Basics and implications
por: Lehtinen, Matti, et al.
Publicado: (2012)

Contribution of smoking change to 45-year trend in prevalence of chronic bronchitis in Finland
por: Vartiainen, Ville A, et al.
Publicado: (2022)

Ambivalence toward euthanasia and physician-assisted suicide has decreased among physicians in Finland
por: Piili, Reetta P., et al.
Publicado: (2022)

Periodontal disease and bacterial vaginosis increase the risk for adverse pregnancy outcome.
por: Oittinen, Juha, et al.
Publicado: (2005)

Periodontal Disease and Bacterial Vaginosis Increase the Risk for Adverse Pregnancy Outcome
por: Oittinen, Juha, et al.
Publicado: (2005)

Detection of Human Papillomavirus DNA by AffiProbe HPV-DNA Test Kit in Cervical Scrapes or Biopsies-Histopathologic Correlates
por: Nieminen, Pekka, et al.
Publicado: (1994)

Cancer Risk Near a Polluted River in Finland
por: Verkasalo, Pia K., et al.
Publicado: (2004)

Impact of smoking on the quantity and quality of antibodies induced by human papillomavirus type 16 and 18 AS04-adjuvanted virus-like-particle vaccine – a pilot study
por: Namujju, Proscovia B, et al.
Publicado: (2014)

Differing Age-Specific Cervical Cancer Incidence Between Different Types of Human Papillomavirus: Implications for Predicting the Impact of Elimination Programs
por: Vänskä, Simopekka, et al.
Publicado: (2020)

Statin Use and Breast Cancer Survival: A Nationwide Cohort Study from Finland
por: Murtola, Teemu J., et al.
Publicado: (2014)

Comparing data sources in estimating disability-adjusted life years (DALYs) for ischemic heart disease and chronic obstructive pulmonary disease in a cross-sectional setting in Finland
por: Paalanen, Laura, et al.
Publicado: (2020)

Association Between Psychological Distress and Incident Dementia in a Population-Based Cohort in Finland
por: Sulkava, Sonja, et al.
Publicado: (2022)

The associations of cardiorespiratory fitness, adiposity and sports participation with arterial stiffness in youth with chronic diseases or physical disabilities
por: Haapala, Eero A, et al.
Publicado: (2017)

Cost-effectiveness analysis of guidelines for antihypertensive care in Finland
por: Booth, Neill, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_iaoociusgiu7h9bc9rb2sasp0a